Efficacy and Safety of Intracoronary Versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome

this meta-analysis was conducted to investigate the clinical efficiency and safety of IC versus intravenous (IV) tirofiban in ACS patients undergoing PCI.

本项荟萃分析（meta-analysis）旨在探究接受经皮冠状动脉介入治疗（Percutaneous Coronary Intervention, PCI）的急性冠脉综合征（Acute Coronary Syndrome, ACS）患者中，冠状动脉内（intracoronary, IC）替罗非班对比静脉内（intravenous, IV）替罗非班的临床疗效与安全性。